-The Hindu Business Line
The drug was developed by the TB Alliance, funded by various governments and philanthropic sources
Hyderabad: The slew of newer TB drugs that have hit the market recently promise to tackle the disease better, but the high price can prove a dampener to realise the goal of taming the deadly disease on a war footing, feel experts, advocacy groups and medical organisations who are meeting this week in Hyderabad for a global event on TB and Lung disease.
Please click here to read more.